<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0253-570X</journal-id>
<journal-title><![CDATA[Revista de Salud Animal]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Salud Anim.]]></abbrev-journal-title>
<issn>0253-570X</issn>
<publisher>
<publisher-name><![CDATA[Centro Nacional de Sanidad Agropecuaria]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0253-570X2011000300001</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[TERMINOLOGY CONCEPTS OF PROBIOTIC AND PREBIOTIC AND THEIR ROLE IN HUMAN AND ANIMAL HEALTH]]></article-title>
<article-title xml:lang="es"><![CDATA[CONCEPTO DE LA TERMINOLOGÍA DE PROBIÓTICOS Y PREBIÓTICOS Y SU ROL EN LA SALUD HUMANA Y ANIMAL]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[Célia Lucia]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Salminen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lukasz]]></surname>
<given-names><![CDATA[Grzeskowiak]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Brizuela]]></surname>
<given-names><![CDATA[Maria Antonieta]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sanchez]]></surname>
<given-names><![CDATA[Lilian]]></given-names>
</name>
<xref ref-type="aff" rid="A04"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carneiro]]></surname>
<given-names><![CDATA[Heloísa]]></given-names>
</name>
<xref ref-type="aff" rid="A05"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bonnet]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<xref ref-type="aff" rid="A05"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Universidade Federal de Viçosa  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="A02">
<institution><![CDATA[,University of Turku Functional Foods Forum ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Finland</country>
</aff>
<aff id="A03">
<institution><![CDATA[,Cuban Research Institute for Sugarcane Derivates (ICDCA)  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A04">
<institution><![CDATA[,National Center for Animal and Plant Health (CENSA)  ]]></institution>
<addr-line><![CDATA[Mayabeque ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="A05">
<institution><![CDATA[,Empresa Brasileira de Pesquisa Agropecuária (EMBRAPA)  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brazil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2011</year>
</pub-date>
<volume>33</volume>
<numero>3</numero>
<fpage>137</fpage>
<lpage>146</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0253-570X2011000300001&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0253-570X2011000300001&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0253-570X2011000300001&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[The mode of action of specific probiotic bacteria and specific prebiotic ingredients and their effects on the intestinal microbiota modulation in humans and animals has been demonstrated in many studies. Intestine is characterized for harboring a complex and dynamic microbiota which, among others, has a function to protect the host from inflammatory disorders. A mature and balanced endogenous microbiota has also an important role in the maintenance of a desirable activity of the immune system. Deviations in gut microbiota composition, due to improper diet, radiotherapy, antibiotic treatment, stress and others, may lead to a variety of gastrointestinal disorders. To overcome an unbalanced microbiota, the consumption of specific probiotics and prebiotics has been proved to be effective. For more than three decades, many probiotic microorganisms have been characterized and evaluated. However, the term prebiotic has only recently been identified, characterized and evaluated in human intervention studies. The list of prebiotic ingredients remains limited, and yacon (Smallantus sonchifolia) is an Andean root to which prebiotic attributes have been inferred recently. Humans and animals could seemingly benefit from the consumption of specific prebiotics and probiotics. In this work, terminology aspects of pre- and probiotics, and their roles in human and animal health are discussed.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Se ha demostrado en muchos estudios el modo de acción de las bacterias probióticas específicas y de determinados ingredientes prebióticos y sus efectos en la modulación de la flora intestinal en humanos y animales. El intestino se caracteriza por hospedar una microbiota compleja y dinámica que, entre otras, tiene como función proteger al huésped de trastornos intestinales. Una microbiota endógena madura y equilibrada, también es importante para el mantenimiento de una actividad deseable del sistema inmunológico. La perturbación de la microbiota intestinal puede tener un impacto en la fisiopatología de una variedad de trastornos gastrointestinales. Para superar este desequilibrio debido a la dieta, radioterapia, terapias con antibióticos, situaciones de estrés y otros, se ha demostrado la eficacia del consumo de probióticos y prebióticos específicos. Durante más de tres décadas, se han descrito y evaluado muchos microorganismos probióticos; sin embargo, el término prebiótico sólo se ha identificado, caracterizado y evaluado recientemente en estudios de intervención humana. La lista de ingredientes prebióticos queda frenada y el yacón (Smallantus sonchifolia) es una raíz andina a la cual los atributos prebióticos se han indicado recientemente. Los seres humanos y animales, aparentemente se podrían beneficiar del consumo de prebióticos y probióticos especiales. En este trabajo se abordarán los aspectos de la terminología de pre y probióticos y su función en la salud humana y animal.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[probiotic]]></kwd>
<kwd lng="en"><![CDATA[Bifidobacterium]]></kwd>
<kwd lng="en"><![CDATA[prebiotic]]></kwd>
<kwd lng="en"><![CDATA[yacon]]></kwd>
<kwd lng="en"><![CDATA[animal health]]></kwd>
<kwd lng="en"><![CDATA[human health]]></kwd>
<kwd lng="es"><![CDATA[probiótico]]></kwd>
<kwd lng="es"><![CDATA[Bifidobacterium]]></kwd>
<kwd lng="es"><![CDATA[prebióticos]]></kwd>
<kwd lng="es"><![CDATA[yacón]]></kwd>
<kwd lng="es"><![CDATA[salud animal]]></kwd>
<kwd lng="es"><![CDATA[salud humana]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <div align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>REVIEW    ARTICLE</b>    <BR>   </font> </div> <H1>&nbsp; </H1> <H1>&nbsp;</H1> <H1><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="4">TERMINOLOGY    CONCEPTS OF PROBIOTIC AND PREBIOTIC AND THEIR ROLE IN HUMAN AND ANIMAL HEALTH</font></B>    </font></H1> <H1>&nbsp;</H1> <H1><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><font size="3">CONCEPTO    DE LA TERMINOLOG&Iacute;A DE PROBI&Oacute;TICOS Y PREBI&Oacute;TICOS Y SU ROL    EN LA SALUD HUMANA Y ANIMAL </font></b></font></H1>     <P>     <P>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>C&eacute;lia    Lucia Ferreira<SUP>*,**</SUP>, S Salminen<SUP>**</SUP>, Lukasz Grzeskowiak<SUP>**</SUP>,    Maria Antonieta Brizuela<SUP>***</SUP>, Lilian Sanchez<SUP>****</SUP>, Helo&iacute;sa    Carneiro<SUP>*****</SUP>, M.Bonnet<SUP>*****</SUP></B> </font>      <P>      <P>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><I><SUP>*</SUP>Universidade    Federal de Vi&ccedil;osa, Av. P.H. Rolfs, Vi&ccedil;osa, MG, Brazil, 36570-000;    <SUP>**</SUP>Functional Foods Forum, University of Turku, 20014 Turku, Finland.    Correspondence: Tel + 55 31 3899-1753; Fax: + 55 31 3899-2208. E-mail: <U><a href="mailto:clferrei@ufv.br">clferrei@ufv.br</a></U>;    <SUP>***</SUP>Cuban Research Institute for Sugarcane Derivates (ICDCA); <SUP>****</SUP>National    Center for Animal and Plant Health<SUP> </SUP>(CENSA), Apdo. 10, San Jos&eacute;    de las Lajas, Mayabeque, Cuba; <SUP>*****</SUP>Empresa Brasileira de Pesquisa    Agropecu&aacute;ria (EMBRAPA) Dairy Cattle, R. Eug&ecirc;nio Nascimento, 610,    Juiz de For a, MG, Brazil 36038-330 </I></font>      <P>     <P> <hr noshade size="1">     ]]></body>
<body><![CDATA[<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>ABSTRACT</B></font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The mode of action    of specific probiotic bacteria and specific prebiotic ingredients and their    effects on the intestinal microbiota modulation in humans and animals has been    demonstrated in many studies. Intestine is characterized for harboring a complex    and dynamic microbiota which, among others, has a function to protect the host    from inflammatory disorders. A mature and balanced endogenous microbiota has    also an important role in the maintenance of a desirable activity of the immune    system. Deviations in gut microbiota composition, due to improper diet, radiotherapy,    antibiotic treatment, stress and others, may lead to a variety of gastrointestinal    disorders. To overcome an unbalanced microbiota, the consumption of specific    probiotics and prebiotics has been proved to be effective. For more than three    decades, many probiotic microorganisms have been characterized and evaluated.    However, the term prebiotic has only recently been identified, characterized    and evaluated in human intervention studies. The list of prebiotic ingredients    remains limited, and yacon (<I>Smallantus sonchifolia</I>) is an Andean root    to which prebiotic attributes have been inferred recently. Humans and animals    could seemingly benefit from the consumption of specific prebiotics and probiotics.    In this work, terminology aspects of pre- and probiotics, and their roles in    human and animal health are discussed. </font>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Keywords:</b>    probiotic; Bifidobacterium; prebiotic; yacon; animal health; human health. </font> <hr noshade size="1">     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RESUMEN</b></font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Se ha demostrado    en muchos estudios el modo de acci&oacute;n de las bacterias probi&oacute;ticas    espec&iacute;ficas y de determinados ingredientes prebi&oacute;ticos y sus efectos    en la modulaci&oacute;n de la flora intestinal en humanos y animales. El intestino    se caracteriza por hospedar una microbiota compleja y din&aacute;mica que, entre    otras, tiene como funci&oacute;n proteger al hu&eacute;sped de trastornos intestinales.    Una microbiota end&oacute;gena madura y equilibrada, tambi&eacute;n es importante    para el mantenimiento de una actividad deseable del sistema inmunol&oacute;gico.    La perturbaci&oacute;n de la microbiota intestinal puede tener un impacto en    la fisiopatolog&iacute;a de una variedad de trastornos gastrointestinales. Para    superar este desequilibrio debido a la dieta, radioterapia, terapias con antibi&oacute;ticos,    situaciones de estr&eacute;s y otros, se ha demostrado la eficacia del consumo    de probi&oacute;ticos y prebi&oacute;ticos espec&iacute;ficos. Durante m&aacute;s    de tres d&eacute;cadas, se han descrito y evaluado muchos microorganismos probi&oacute;ticos;    sin embargo, el t&eacute;rmino prebi&oacute;tico s&oacute;lo se ha identificado,    caracterizado y evaluado recientemente en estudios de intervenci&oacute;n humana.    La lista de ingredientes prebi&oacute;ticos queda frenada y el yac&oacute;n    (<I>Smallantus sonchifolia</I>) es una ra&iacute;z andina a la cual los atributos    prebi&oacute;ticos se han indicado recientemente. Los seres humanos y animales,    aparentemente se podr&iacute;an beneficiar del consumo de prebi&oacute;ticos    y probi&oacute;ticos especiales. En este trabajo se abordar&aacute;n los aspectos    de la terminolog&iacute;a de pre y probi&oacute;ticos y su funci&oacute;n en    la salud humana y animal.</font>  <B></B>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Palabra claves:</b>    probi&oacute;tico; Bifidobacterium; prebi&oacute;ticos; yac&oacute;n; salud    animal; salud humana.</font>      <P>     <P>      <p>      <p>      ]]></body>
<body><![CDATA[<p>      <p>      <p>      <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>(Recibido 9-8-2011;    Aceptado 23-10-2011)</b> </font> <hr noshade size="1">     <p>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">    <BR>   <B><font size="3">INTRODUCTION</font></B> </font>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Intestine is characterized    for harboring a complex and dynamic microbiota which, among others, has a function    to protect the host from intestinal disorders. A mature and balanced endogenous    microbiota, has also an important role in the maintenance of a desirable activity    of the immune system. To overcome an unbalanced microbiota, due to improper    diet, radiotherapy, antibiotic treatment, stress situations and others, the    consumption of specific probiotics and prebiotics has been proved to be effective.    Probiotics are defined as &#171;live microorganisms which when administered    in adequate amounts confer a health benefit on the host&#187; (1).Prebiotics    are defined as &#171;non-viable food component that confers a health benefit    on the host associated to microbiota&#187; modulation (2). Product containing    probiotic (s) and prebiotic (s) is called synbiotic. </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">For more than three    decades, many probiotic microorganisms have been described and evaluated. However,    the term prebiotic has only recently been identified, characterized and evaluated    in human intervention studies. The list of prebiotic ingredients remains limited.    The prebiotic activities of yacon(<I>Smallantus sonchifolia</I>), originally    an Andean root, have only been recently studied (3) . Humans and animals could    seemingly benefit from the consumption of specific probiotic and prebiotic.    Though there are the numerous functions of pre- and probiotics attributed to    different health conditions in humans and animals, the most studied are related    to the modulation of the intestinal microbiota. </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In this work, the    terminology of the main topics related to pre- and probiotics, the main probiotic    organisms and prebiotic ingredients with emphasis in yacon, as well as their    roles in human and animal health have been discussed. </font>     ]]></body>
<body><![CDATA[<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Intestinal microbiota</B>    </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Varieties of organisms    such as protozoa, bacteriophage, fungi and bacteria are normal residents of    the gastrointestinal tract (GIT). From these, intestinal bacteria are the most    studied entity. This microbiota complies with more than 500 cultivable species    (4) achieving the highest densities not found in any other studied ecosystem    (5). However, studies using modern molecular techniques have indicated that    more than 1000 species are present in the gut. This complex community is metabolically    active and contributes to homeostasis (6). The gut microbiota composition varies    with race, sex, age, diet and other factors (7). It possesses key functions    such as: </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> i) fermentation    of intestinal mucus produced by epithelial cells (8), ii) metabolism of bilirubin,    cholesterol, bile acids, steroid hormones, pancreatic enzymes, fatty acids (9,    10 ), iii) nutritional activity such as providing the host with vitamins K and    B (11) and contributing to the protein homeostasis of the host via synthesis    of aminoacids, iv) immune functions, acting for example, in the stimulation    of the innate and adaptative immunity, aiding the host to respond more quickly    to pathogen challenge (12, 13) and v) &#171;colonization resistance&#187;, a    phenomenon characterized namely by the resisting of colonization of opportunistic    pathogens that preferentially overgrew due to inflammation or use of specific    medications and broad-spectrum antibiotic (14). When microbiota is disrupted,    the host becomes more susceptible to infections. In addition, antibiotic therapy    affects microbial homeostasis, which can be recovered in a time period as long    as eight weeks after discontinuity of antibiotic therapy (15). This situation    leads to the potential use of specific probiotics and prebiotics which act aiding    to a faster re-establishment of the normal intestinal microbial community in    the host gut. This microbial community, estimated in 10<SUP>14 </SUP>cells,    varies quantitatively and qualitatively along with the different environments    from the stomach, small and large intestines and outnumbers the total human    eukaryotic cells (10<SUP>13</SUP>) ( 16, 17). </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Different habitats    are encountered in the stomach, small and large intestines, leading to a qualitative    and quantitative diversity of bacteria families, genera and species. </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Stomach microbiota</B>.    The numbers of the adapted resident bacteria and fungi are controlled by the    acidic environment found in this habitat. Among the described genera usually    found in the stomach are <I>Actinomyces</I>, <I>Fusobacterium</I>, <I>Peptostreptococcus</I>,    <I>Streptococcus</I>, <I>Staphylococcus</I> and <I>Veillonella</I>. The concentration    of microrganisms in the stomach is low, barely reaching levels of 10<SUP>3 </SUP>    CFU/g of gastric content (16). As pH increases along the gastrointestinal tract    (GIT), the microbial numbers increase. </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Small intestine    microbiota</B>. The small intestine is a transitional zone between the stomach    and the colon. The presences of bile, pancreatic juices and others, as well    as the high rate of motility are among the main variables responsible for controlling    microbial overgrowth in the small intestine. Facultative microorganisms predominate    and their numbers are in the range of 10<SUP>4</SUP>-10<SUP>8</SUP> CFU/g of    the small intestine content (12). The ileum harbours a transition microbiota,    the numbers of anaerobes increase and the presence of coliforms and species    of the genera <I>Bacteroides</I>, <I>Fusobacterium</I> and <I>Lactobacillus    </I>is common. Bacterial concentration in the ileum reaches 10<SUP>9 </SUP>CFU/g    (12). </font>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Large intestine    microbiota</B>. Anaerobes predominate in the large intestine of mammals. The    proximal colon is characterized by a high concentration of substrates, a pH    in the range of 5-6, and a rapid microbial growth with accumulation of short    chain fatty acids (SCFA), while in the distal colon substrate is less available,    pH is close to neutrality and putrefactive fermentation predominates (18). Colonic    microbiota consists of large numbers of anaerobes and the presence of genera    from the <I>Enterobacteriaceae</I> and species of <I>Enterococcus</I>, <I>Bacteroides</I>,    <I>Fusobacterium</I>, <I>Clostridium </I>and <I>Bifidobacterium</I> is common    (16,19). The densities achieved reach concentrations up to 10<SUP>11</SUP> to    10<SUP>13</SUP> CFU/g of colonic content (20). </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The faecal content    has the highest concentration of microorganisms, and bacteria comprise 33% of    its dry weight (7). Species belonging to <I>Bacteroide</I>, <I>Clostridium</I>    and <I>Bifidobacterium</I> genera have been found to predominate in human faeces    (21), whereas in rats, the leading genera are <I>Staphylococcus</I>, <I>Enterococcus</I>,    <I>Serratia</I> and <I>Proteus</I> (22). </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">This diversity    of pathogenic and saprophytic microorganisms exists in equilibrium, and the    consumption of probiotics, prebiotics and synbiotics have been considered potential    alternatives to counteract its disruption. </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>The concept    of probiotic and probiotic-like microorganism</B> </font>     ]]></body>
<body><![CDATA[<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Concerning and    understanding the concepts and terminologies of functional foods including probiotic/prebiotic/synbiotic    have been materialized in a recent publication (23). For the first time conceptual    diagrams depict probiotic and prebiotic from origin to labelling. With the increasing    of globalization, the terminology work in specific areas is of utmost importance    for economic and scientific reasons. Knowing the possibilities of a probiotic    origin might help the search for new probiotic species in similar ecological    niches. It is also important to differentiate a probiotic from a probiotic-like    microorganism. A <U>probiotic species</U> is defined as &#171;species of safe    bacterium originated from the host, mainly from the intestinal tract, and/or    fungus originated from plant which when administered in adequate amounts confer    a health benefit&#187;. <U>Probiotic microorganism</U> refers to &#171;safe    bacterium originated from the host intestinal tract which when administered    in adequate amounts confers a health benefit&#187;, and a <U>probiotic-like    microorganism</U> refers to safe bacterium and/or fungus originated from other    sources of the host intestinal tract which when administered in adequate amounts    confer a health benefit&#187; (23). <a href="/img/revistas/rsa/v33n3/f0101311.gif">Figure    1</a> indicates a conceptual relation of these terms. </font>      
<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The most common    probiotic microorganisms are species belonging to the genera <I>Lactobacillus</I>    and <I>Bifidobacterium</I> for humans and <I>Bacillus</I>, </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">    <BR>   <I>Enterococcus</I>, <I>Lactobacillus</I>, <I>Aspergillus</I> and <I>Saccharomyces</I>    for animals. </font>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Probiotics are    marketed in different formats (<a href="/img/revistas/rsa/v33n3/f0201311.gif">Fig.    2</a>). </font>      
<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The main probiotic    functions are indicated in <a href="/img/revistas/rsa/v33n3/f0301311.gif">figure    3</a>. </font>      
<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>The prebiotic    concept</B> </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Natural defenses    of human and animals could be enhanced with the inclusion of functional foods    into human food and animal feed. Nowadays, the prebiotics available are mainly    carbohydrate in nature. They are not metabolized at the upper intestine but    rather by the microbiota in the colon. Acting as main energy source, prebiotics    stimulate the growth of beneficial microorganisms such as bifibacteria; and    for this reason prebiotics were firstly known as bifidogenic factors. Also other    microbial groups might be stimulated as well. This stimulus is followed by accumulation    of metabolites, mainly SCFA (acetate, butyrate, and propionate) responsible    for the maintenance of a desirable dynamic microbiota and innate/specific immune    markers important for the host health. Prebiotics currently marketed are disaccharide,    oligosaccharide and resistant starch in nature (<a href="/img/revistas/rsa/v33n3/f0401311.gif">Fig    4</a>). Inulin-type prebiotics are among the most commercialized and studied    prebiotics. Inulin and fructooligosaccharides share this same nature. They are    carbohydrates and, as such, are classified according to their degree of polymerization,    i.e., according to the number of monosaccharide units combined. They are also    classified as non- digestible, as the anomeric carbon atom (C1 or C2) of the    monosaccharide unit of the oligosaccharide has a configuration that makes their    osidic bonds unsusceptible to the hydrolytic human enzymes. Inulin (3-60 sugar    moieties) and fructooligosaccharides (3-20 sugar moieties) are linear &acirc;    2'!1 fructans which are present in a variety of plants ( 24, 25 ).    
<BR>       <BR>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2"></font>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Currently, many    non-digestible oligosaccharides (NDOs) are commercialized as food ingredients.    They are carbohydrates in which the monosaccharides unit is glucose, galactose,    fructose and xylose. Thirteen commercialized types of NDO have been described:    i) cyclodextrin, ii) fructooligosaccharide, iii) galactooligosaccharide, iv)    gentiooligosaccharide, v) glycosilsucrose, vi) isomaltooligosaccharide, vii)    lactosucrose, viii) lactulose, ix) maltooligosaccharide, x) raffinose, xi) soybeanoligosaccharide,    xylooligosaccharide (26). Production processes of some NDO are indicated on    <a href="/img/revistas/rsa/v33n3/t0101311.gif">Table 1</a>. </font>      
]]></body>
<body><![CDATA[<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">From the currently    known NDO, the inulin-type ingredients - inulin and fructooligosaccharides (FOS)    - are the most commercialized and studied. These compounds have many important    properties, making them suitable alternatives in the process of balancing a    disturbed colon microbiota, thereby inhibiting many undesirable diseases. </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A summary of the    main benefits imparted to the consumption of prebiotics is indicated in <a href="/img/revistas/rsa/v33n3/f0501311.gif">Figure    5</a>. </font>      
<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Many of the functions    of prebiotics are part of the portfolio of probiotic functions, as the promoter    of such benefits relies in the modulated microbiota (<a href="/img/revistas/rsa/v33n3/f0401311.gif">fig.    4</a> and <a href="/img/revistas/rsa/v33n3/f0501311.gif">fig. 5</a>). </font>      
<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Nowadays, commercial    FOS are mainly originated from extraction/hydrolysis of Jerusalem artichoke    and chicory. However, recently renewed interest has been directed to a rediscovered    crop from the Andes, the yacon (<I>Smallanthus sonchifolius</I>), which harbors    a much higher concentration of FOS. In this fruit-like root sugar FOS is stored    instead of starch. Yacon is so rich in FOS that &#171;an effective prebiotic    dose can be achieved by only consuming the root in moderate amounts&#187;(27    ). To date, most of the yacon studies are upon its antidiabetic effect (28).    Other studies indicated    that colonic transit was ameliorated in volunteers (29), positive effect was    detected on calcium/magnesium balance and bone calcium retention in rats (30)    and that no adverse effect on rats was detected through an oral toxicity evaluation    (31). Important finding is the potential of yacon to be used as prebiotic and    to control obesity and insulin resistance in humans (32). The richness of the    yacon in bio-ingredients and functionality has recently been highlighted as    it has been indicated as novel food candidate to the EU market (27). Therefore    it is important that more clinical studies be undertaken to clarify the mechanistic    effect of yacon consumption as this functional food might have an important    role in public health to mitigate the effects of a number of chronic conditions    affecting the growing aging population.     <BR>       <BR>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">    <BR>   <B>Health effect of probiotics and prebiotics</B> </font>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">There is an increasing    evidence that pro- and prebiotics can play a role in alleviating some diseases    and conditions as summarized in figures 4 and 5. It is important, however, to    highlight that almost all of these effects rely on the beneficial modulation    of the intestinal microbiota and in the increasing importance that pro- and    prebiotics have in the modulation of different types of diarrhea, as they represent    &#171;supportive therapy for conditions established by the disruption of the    normally protective microbiota&#187; (14). </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In animal husbandry    and management, pro- and prebiotics are emerging as important tools to fight    microbial unbalance mainly during stress conditions. Reductions in pathogenic    and increases in desirable intestinal bacteria can result in local and systemic    immune activation, rendering animals healthier and increasing their performance.    </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Promising results    have been found upon administration of probiotics in swine, poultry, cattle    and sheep. The surge in popularity of the application of probiotic in the agriculture    industry relies basically upon its potential for livestock growth promotion    especially after the 2006 EU-wide ban on in-feed antibiotic growth enhancers.    The physiological state of animals influences their performance (33). In swine,    the weaning period has a great economic impact due to the common occurrence    of intestinal disorders, and this transition time is characterized by changes    in the feeding procedure and in the relation of the siblings with the sows.    Furthermore, this separation at an early age (usually 21 days), coupled with    an immature intestine, exacerbate animal stress. At this stage, a probiotic    function such as barrier, competitively excludes pathogens. This mechanism is    also promising in animals after treatment with antibiotics, mainly in the prevention    of <I>Salmonella</I> infection. In previous studies, body weight was improved    upon supplementation of weaned pigs with <I>Lactobacillus sobrius</I> and challenged    with <I>E. coli</I> K88 (34). In another report, <I>E. faecium</I> and <I>E.</I>    <I>faecalis </I>have been used in several clinical trials, albeit not proposed    by QPS (35). Baum and colleagues found that sows&#180; diet supplemented with    <I>Enterococcus faecium</I> protected one week post weaned piglets from diarrhea.    They also reported that weaned pigs had improved growth after 4 months of feed    consumption containing <I>Saccharomyces boulardii</I> (36). </font>     ]]></body>
<body><![CDATA[<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> The main stressors    in broiler production are related to post hatching, transportation and stocking    densities (37). The poultry intestinal microbiota seems to have an effect on    growth, egg production and feed conversion, and probiotic use is directed to    maintain the health state by enhancing the competitive exclusion (CE) of pathogens    (38). The term Competitive Exclusion is also known as the Nurmi concept, and    has originated from the observation that <I>Salmonella </I>was inhibited when    the infected bird was fed with a suspension containing gut material from a healthy    adult chicken (39). The CE is seen as a main alternative to maintain a healthy    gut in poultry studies. An artificially infected hatchery experiment with <I>Salmonella    enteriditis</I> (10<SUP>4</SUP> CFU) indicated that chicks receiving doses of    <I>Lactobacillus</I> FM-B11 (10<SUP>6-8</SUP> CFU) were protected from the infection    (40). Natural antibodies for some antigens was increased in serum and gut of    chicks following ingestion of a mix of <I>Lactobacillus acidophilus</I>, <I>Bifidobacterium    bifidum </I>and <I>Enterococcus faecalis</I> (41). Probiotics are a good strategy    to maintain pathogens at bay, thus protecting the gut microbiota of poultry    and other production animals. Although prebiotic use in this area is quite new,    conflicting results have already been reported (42). Comprehensive reviews on    these subjects are indicated elsewhere (43, 17, 27). </font>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Considering that    probiotics and prebiotics are part of functional foods, it is important to remember    the main features for the maintenance of such ingredients within that classification    are basically twofold: i) to be consumed with the normal, everyday diet, ii)    have a positive effect on target function(s) that may enhance well-being and    health, and/or reduce the risk of disease. </font>     <P>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">CONCLUSION</font></B>    </font>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Within the last    decade, studies on the relationship of human/ animal gut microbiota and immunology    have shed light to the role of probiotics and prebiotics on the health of mammals.    Evidences exist pertaining the influence that pro-, pre- and synbiotics have    in the microecology of the intestines of human and animals, and their role in    alleviating various diseases. Microbial ecology coupled with the understanding    of the human genome have &#171;paved the path for the clarifying of the mechanisms    involved with the health effects of probiotics and prebiotics&#187; (44). Because    of the large amount of evidence and diversity of the beneficial effects of these    functional foods/ingredients, presently their potential could be considered    underestimated. The contingent of individuals aged 65 or older is increasing    globally, which constitutes a public health concern. Functional foods are now    part of the modern thinking based on prevention and/or alternatives for decreasing    the risk associated to chronic diseases. Furthermore, the concerning of maintaining    &#171;cleaner&#187; feeds to curb dysbiosis in humans and animals has increased    the use of pro- and prebiotics for the promotion of livestock growth, specially    after the 2006 EU-wide ban on in-feed antibiotic growth enhancers. Probiotic,    prebiotic and synbiotic food, feed supplements and ingredients abound the market,    albeit confirmation of the benefits and mechanisms of action still remains mostly    putative. Still, they constitute important tools to help maintaining humans    and animals in good health. </font>      <P>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">ACKNOWLEDGEMENTS</font></B>    </font>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The authors thank    CAPES, CNPq and FAPEMIG, Brazil. </font>     <P>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">REFERENCES</font></B>    </font>      ]]></body>
<body><![CDATA[<!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. FAO. Report    of a Joint FAO/WHO Working Group on Drafting Guidelines for the evaluation of    probiotics in food. London, Ontario, Canada, 30 April 1 May 2002. Available    from: <a href="http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf" target="_blank">http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf</a>.    June 30th, 2010.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. FAO FAO Technical    Meeting on Prebiotics. Food Quality and Standards Service (AGNS), food and Agriculture    Organization of the United Nations (FAO), September 2007, <a href="http://www.fao.org/ag/agn/agns/files/Prebiotics_Tech_Meeting_%20Report.pdf" target="_blank">http://www.fao.org/ag/agn/agns/files/Prebiotics_Tech_Meeting_    Report.pdf</a>. June 10th, 2010.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. Pedreschi R,    Campos D, Norato G, Chirinos R, Zevallos L. Andean yacon root (<I>Smallanthus    sonchifolius</I> Poepp. Endl) frooligosaccharides as a potential novel source    of prebiotics. J Agric Food Chem. 2003;51:5278-5284.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Moore WE, Holdeman    LV. Special problems associated with the isolation and identification of intestinal    bacteria in fecal flora studies. Am J Clin Nutr. 1974; 27:1450-1455.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. B&auml;ckhead    F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in    the human intestine. Science. 2005;307:1915-1920.     </font>      ]]></body>
<body><![CDATA[<!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6. Rajilic-Stojanovic    M, Smidt H, de Vos WM. Diversity of the human gastrointestinal tract microbiota    revisited. Environ Microbio. 2007;9(0):2125-2136.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7. Simon GL, Gorbach    SL. Intestinal microflora. Med Clin North Am. 1982;66(3):557-574.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8. Roberfroid MB,    Bornet F, Bouley C, Cummings JH. Colonic microflora: nutrition and health. Nutrition    Reviews. 1995;53:127-130.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9.Gorbach SL. Intestinal    microflora. Gastroenterology. 1971; 60(6):1110-1129.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10.Umesaki Y, Okada    Y, Imaoka K, Setoyama H, Matsumoto S. Interactions between Epithelial cells    and bacteria, normal and pathogenic. Science. 1997;276(5314):964-965.     </font>     ]]></body>
<body><![CDATA[<!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11.Conly JM, Stein    L, Worobetz L, Rutlege-Harding S. The contribution of vitamin K2 produced by    the intestinal microflora to human nutritional requirements for vitamin K. Am    J Gastroenterol. 1994; 89:915-923.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12.Berg RD. The    indigenous gastrointestinal microbiota. Trends Microbiol. 1996;4:430-435.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13.Rhee KJ, Setupahy    P, Driks A, Lanning DK, Knight KL. Role of commensal bacteriain development    of gut- associate lymploid tissue and preimmune antibody repertoire. J Immunol.    2004; 172(2):1118-1124.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14.McFarland LV.    Normal flora: diversity and functions. Microbial Ecology in Health and Disease.    2000; 12:193-207.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">15.McFarland LV,    Elmer GW, McFarland M. Meta-analysis of probiotics for the preventionand treatment    of acute pediatric diarrhea. International Journal of Probiotics and Prebiotics.    2006;1(1):63-76.     </font>     ]]></body>
<body><![CDATA[<!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">16.Tannock GW.    Normal microflora. London, Cgapman &amp; Hall, 1995.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">17.Jacobs DM, Gaudier    E, Duynhoven J, Vaughn EE. Non digestible Food ingredients, colonic microbiota    and the impact on gut health and immunity: a role for metabolomics. Current    Drug Metabolism. 2009;10:41-54.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">18.Cummings JH,    Pomare EW, Brabch WJ, Naylor CP, MacFarlane DT. Short chain fatty acids in human    large intestine, portal, hepatic and venous blood. Gut. 1987; 28:1221-1227.        </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">19.Dunne C. Adaptation    of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm Bowel    Dis. 2001; 136-145.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">20.Simon GL, Gorbach    SL. Intestinal flora in health and disease. Gastroenterology. 1984; 86:174-196.        </font>     ]]></body>
<body><![CDATA[<!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">21.Matsuki T, Watanabe    K, Fujimoto J, Kado H, Takada T, Matsumoto K, et al. Quantitative PCR with 16S    rRNA-gene-targeted species-specific primers for analysis of human intestinal    Bifidobacteria. Appl. Environm Microbiol. 2004;70(1):167-173.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">22.Stringer AM,    Gibson RJ, Lujan RM, Bowen JM, Yeoh AS-J, Burn J, Keefe DMK. Chemotherapy-induced    diarrhea is assocated with changes in the luminal environment in the DA rat.    Experimental Biology and medicine. 2007;232(1): 96-106.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">23.Magalh&atilde;es    MS, Salminen S, Anna P, Marchelli R, Ferreira CL, Tommola J. Terminology: Functional    Foods, Probiotics, Prebiotics, Synbiotics, Health claims, Sensory evaluation    of foods, Molecular gastronomy. English-portuguese-italian edition. Magalh&atilde;es    MS, Salminen S, Anna P, Marchelli R, Ferreira CL, Tommola J. (Eds) Functional    Foods Forum, University of Turku (Ed), Finland, 2011. 122p.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">24.Roberfroid MB,    Slavin J. Non digestible oligosaccharides. Critical Review in Food Science and    Nutrition. 2002; 40:461-480.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">25.Roberfroid MB.    Functional Foods: concepts and application to inulin and oligofructose. Br J    Nutr . 2000; 87, suppl 2, S129-S143.     </font>     ]]></body>
<body><![CDATA[<!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">26.Sako T, Matsumoto    K, Tanaka R. Recent progress on research and applications of non-digestible    galacto-oligosaccharidesInternational. Dairy Journal .1999;9:69-80.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">27.Ojansivu I,    Ferreira CL, Salminen S. Yacon, A new source of prebiotic oligosaccharides with    history of safe use. Trends in Food Sci and Technol. 2011;22:40-46.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">28.Aybar MJ, Riera    ANS, Grau A, Sanchez SS. Hypoglicemic effect of the water extract of Smallanthus    sonchifolius (yacon) leaves in normal and diabetic rats. J Ethopharmacology.    2001;74:125-132.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">29.Geyer M, Manrique    I, Degen L, Belinger C. Effect of Yacon (Smallanthus sonchifolius) on colonic    transit time in healthy volunteers. Digestion. 2008;78:30 -33.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">30.Lobo A, Colli    C, Eliana P, Tulia M. Effects of fructans containing yacon (Smallanthus sonchifolius    Poepp&amp;Endl) flour on caecum mucosal morphometry, calcium and magnesium balance,    and bone calcium retention in growing rats. British J of Nutr. 2007; 97:776-785.        </font>      ]]></body>
<body><![CDATA[<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">31.Genta SB, Cabrera    WM, Grau A, Sanchez SS. Subcronic 4-month oral toxicity study of dried Smallathus    sonchifolius (yacon) roots as a diet supplementation in rats. 2005; Food and    Chem Toxicol 43; 1657-1665. </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">32.Genta S, Cabrera    W, Habib NP, Pons J, Manrique CI, Grau A, et al. Yacon syrup: beneficial effects    on obesity and insulin resistance in human. Clinical Nutr 2009; 28:182-187.        </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">33.Corcionivoschi    N, Drinceanu D, Pop IM, Stack D, Stef L, Bourke CJB. The effect of probiotics    on animal health. Animal Sc and Tecnol. 2010; 43(1):35-41.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">34.Konstantinov    SR, Awati A, Smidt H, Williams BA, Akkermans AD, de Vos WM. Specific response    of a novel and abundant <I>Lactobacillus amylovorus</I>-like phylotype to dietary    prebiotics in the guts of weaning piglets. Appl Environ Microbiol. 2004; 70:3821-3830.        </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">35.EFSA. European    Food Safety Authority. Opinion pf the scientific committee on a request from    EFSA related to a generic approach to the safety assessment by EFSA o microorganisms    used in food/feed additives. EFSA journal. 2007;22: 6 1-12.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">36.Baum B, Lieber-Tenorio    EM, Enss ML, Pohlenz JL, Breves G. <I>Saccharomyces boulardii</I> and <I>Bacillus    cereus</I> var <I>Toyoi</I> influence the morphology and mucins of the intestine    of pigs. Z Gastroenterol. 2002; 40:277-284.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">37.Pinsachov J,    Noy Y. Comparison of post-hatch holding time and subsequent early performance    of broiler hicks and turkey pouts. Br Poultry Sci. 1993;34:111-120.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">38.Stern NJ, Svetoch    EA, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, et al Isolation    o a <I>Lactobacillus salivarius</I> strain and purification of its bacteriocin,    which is inhibitory to <I>Campylobacter jejuni </I>in the chicken gastrointestinal    system. Antimicrob Agents Chemother. 2006; 50:3111-3116.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">39.Nurmi E, Rantala    M. New aspects of Salmonella infection in broiler production. Nature 1973; 241:210-211.        </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">40.Huggins SE,    Higgins JP, Wollfenden AD, Henderson SN, Torres-Rodriguez A, Tellez G, et al.    Evaluation of a Lactobacillus based probiotic culture for the reduction of <I>Salmonella</I>    <I>enteriditis</I> in neonatal broiler chicks. Poult Sci. 2008; 87:27-31.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">41.Haghighi HR,    Gong J, Gyles CL, Hayes MA, Zhou H, Saneri B, et al. Probiotics stimulates production    of natural antibodies in chicken. Clin Vaccine Immunol. 2006; 13:975-980.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">42.Yang Y, lji    PA, Choc M. Dietary modulation of gut microflora in broiler chickens: a review    of the role of six kinds of alternatives to in-feed antibiotics. World's Poultry    Science Journal. 2009. 65:97-101.     </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">43.Mussato SI,    Mancilla IM. Non-digestible oligosaccharides: A review. Carbohydrate Polimers.    2007;68:587-597.     </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">44.Reid G, Sanders    ME, Gaskins HR, Gibson G, Mercenier A, Rastall R, et al. New Scientific Paradigms    for probiotics and prebiotics. J Clin Gatroenterol. 2003;37(2):105-118.     </font>      <P>     <P>      ]]></body>
<back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<source><![CDATA[Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the evaluation of probiotics in food]]></source>
<year>2010</year>
<publisher-name><![CDATA[FAO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<source><![CDATA[FAO Technical Meeting on Prebiotics. Food Quality and Standards Service (AGNS)]]></source>
<year>2010</year>
<publisher-name><![CDATA[FAO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pedreschi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Norato]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Chirinos]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Zevallos]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Andean yacon root (Smallanthus sonchifolius Poepp. Endl) frooligosaccharides as a potential novel source of prebiotics]]></article-title>
<source><![CDATA[J Agric Food Chem]]></source>
<year>2003</year>
<volume>51</volume>
<page-range>5278-5284</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moore]]></surname>
<given-names><![CDATA[WE]]></given-names>
</name>
<name>
<surname><![CDATA[Holdeman]]></surname>
<given-names><![CDATA[LV]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Special problems associated with the isolation and identification of intestinal bacteria in fecal flora studies]]></article-title>
<source><![CDATA[Am J Clin Nutr]]></source>
<year>1974</year>
<volume>27</volume>
<page-range>1450-1455</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bäckhead]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ley]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Sonnenburg]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Peterson]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Gordon]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Host-bacterial mutualism in the human intestine]]></article-title>
<source><![CDATA[Science]]></source>
<year>2005</year>
<volume>307</volume>
<page-range>1915-1920</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rajilic-Stojanovic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Smidt]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[de Vos]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Diversity of the human gastrointestinal tract microbiota revisited]]></article-title>
<source><![CDATA[Environ Microbio]]></source>
<year>2007</year>
<volume>9</volume>
<numero>0</numero>
<issue>0</issue>
<page-range>2125-2136</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Gorbach]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Intestinal microflora]]></article-title>
<source><![CDATA[Med Clin North Am]]></source>
<year>1982</year>
<volume>66</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>557-574</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roberfroid]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Bornet]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bouley]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cummings]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Colonic microflora: nutrition and health]]></article-title>
<source><![CDATA[Nutrition Reviews]]></source>
<year>1995</year>
<volume>53</volume>
<page-range>127-130</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gorbach]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Intestinal microflora]]></article-title>
<source><![CDATA[Gastroenterology]]></source>
<year>1971</year>
<volume>60</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1110-1129</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Umesaki]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Okada]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Imaoka]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Setoyama]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Matsumoto]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Interactions between Epithelial cells and bacteria, normal and pathogenic]]></article-title>
<source><![CDATA[Science]]></source>
<year>1997</year>
<volume>276</volume>
<numero>5314</numero>
<issue>5314</issue>
<page-range>964-965</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conly]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Stein]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Worobetz]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rutlege-Harding]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The contribution of vitamin K2 produced by the intestinal microflora to human nutritional requirements for vitamin K]]></article-title>
<source><![CDATA[Am J Gastroenterol]]></source>
<year>1994</year>
<volume>89</volume>
<page-range>915-923</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berg]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The indigenous gastrointestinal microbiota]]></article-title>
<source><![CDATA[Trends Microbiol]]></source>
<year>1996</year>
<volume>4</volume>
<page-range>430-435</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rhee]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Setupahy]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Driks]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lanning]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
<name>
<surname><![CDATA[Knight]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Role of commensal bacteriain development of gut- associate lymploid tissue and preimmune antibody repertoire]]></article-title>
<source><![CDATA[J Immunol]]></source>
<year>2004</year>
<volume>172</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1118-1124</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McFarland]]></surname>
<given-names><![CDATA[LV]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Normal flora: diversity and functions]]></article-title>
<source><![CDATA[Microbial Ecology in Health and Disease]]></source>
<year>2000</year>
<volume>12</volume>
<page-range>193-207</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McFarland]]></surname>
<given-names><![CDATA[LV]]></given-names>
</name>
<name>
<surname><![CDATA[Elmer]]></surname>
<given-names><![CDATA[GW]]></given-names>
</name>
<name>
<surname><![CDATA[McFarland]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Meta-analysis of probiotics for the preventionand treatment of acute pediatric diarrhea]]></article-title>
<source><![CDATA[International Journal of Probiotics and Prebiotics]]></source>
<year>2006</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>63-76</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tannock]]></surname>
<given-names><![CDATA[GW]]></given-names>
</name>
</person-group>
<source><![CDATA[Normal microflora]]></source>
<year>1995</year>
<publisher-loc><![CDATA[^eLondon London]]></publisher-loc>
<publisher-name><![CDATA[Cgapman & Hall]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacobs]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Gaudier]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Duynhoven]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vaughn]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Non digestible Food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics]]></article-title>
<source><![CDATA[Current Drug Metabolism]]></source>
<year>2009</year>
<volume>10</volume>
<page-range>41-54</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cummings]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Pomare]]></surname>
<given-names><![CDATA[EW]]></given-names>
</name>
<name>
<surname><![CDATA[Brabch]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Naylor]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[MacFarlane]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Short chain fatty acids in human large intestine, portal, hepatic and venous blood]]></article-title>
<source><![CDATA[Gut]]></source>
<year>1987</year>
<volume>28</volume>
<page-range>1221-1227</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dunne]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Adaptation of bacteria to the intestinal niche: probiotics and gut disorder]]></article-title>
<source><![CDATA[Inflamm Bowel Dis]]></source>
<year>2001</year>
<page-range>136-145</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Gorbach]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Intestinal flora in health and disease]]></article-title>
<source><![CDATA[Gastroenterology]]></source>
<year>1984</year>
<volume>86</volume>
<page-range>174-196</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Matsuki]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Watanabe]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Fujimoto]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kado]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Takada]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Matsumoto]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal Bifidobacteria]]></article-title>
<source><![CDATA[Appl. Environm Microbiol]]></source>
<year>2004</year>
<volume>70</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>167-173</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stringer]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Gibson]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lujan]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Bowen]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Yeoh]]></surname>
<given-names><![CDATA[AS-J]]></given-names>
</name>
<name>
<surname><![CDATA[Burn]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Keefe]]></surname>
<given-names><![CDATA[DMK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Chemotherapy-induced diarrhea is assocated with changes in the luminal environment in the DA rat]]></article-title>
<source><![CDATA[Experimental Biology and medicine]]></source>
<year>2007</year>
<volume>232</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>96-106</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Magalhães]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Salminen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Anna]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Marchelli]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Tommola]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Terminology: Functional Foods, Probiotics, Prebiotics, Synbiotics, Health claims, Sensory evaluation of foods, Molecular gastronomy]]></source>
<year>2011</year>
<page-range>122</page-range><publisher-name><![CDATA[Functional Foods Forum, University of Turku]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roberfroid]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Slavin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Non digestible oligosaccharides]]></article-title>
<source><![CDATA[Critical Review in Food Science and Nutrition]]></source>
<year>2002</year>
<volume>40</volume>
<page-range>461-480</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roberfroid]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Functional Foods: concepts and application to inulin and oligofructose]]></article-title>
<source><![CDATA[Br J Nutr]]></source>
<year>2000</year>
<volume>87</volume>
<numero>^s2</numero>
<issue>^s2</issue>
<supplement>2</supplement>
<page-range>S129-S143</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sako]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Matsumoto]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Tanaka]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Recent progress on research and applications of non-digestible galacto-oligosaccharidesInternational]]></article-title>
<source><![CDATA[Dairy Journal]]></source>
<year>1999</year>
<volume>9</volume>
<page-range>69-80</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ojansivu]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Salminen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Yacon, A new source of prebiotic oligosaccharides with history of safe use]]></article-title>
<source><![CDATA[Trends in Food Sci and Technol]]></source>
<year>2011</year>
<volume>22</volume>
<page-range>40-46</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aybar]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Riera]]></surname>
<given-names><![CDATA[ANS]]></given-names>
</name>
<name>
<surname><![CDATA[Grau]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchez]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Hypoglicemic effect of the water extract of Smallanthus sonchifolius (yacon) leaves in normal and diabetic rats]]></article-title>
<source><![CDATA[J Ethopharmacology]]></source>
<year>2001</year>
<volume>74</volume>
<page-range>125-132</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Geyer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Manrique]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Degen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Belinger]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Effect of Yacon (Smallanthus sonchifolius) on colonic transit time in healthy volunteers]]></article-title>
<source><![CDATA[Digestion]]></source>
<year>2008</year>
<volume>78</volume>
<page-range>30 -33</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lobo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Colli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Eliana]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Tulia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Effects of fructans containing yacon (Smallanthus sonchifolius Poepp&Endl) flour on caecum mucosal morphometry, calcium and magnesium balance, and bone calcium retention in growing rats]]></article-title>
<source><![CDATA[British J of Nutr]]></source>
<year>2007</year>
<volume>97</volume>
<page-range>776-785</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Genta]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
<name>
<surname><![CDATA[Grau]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchez]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Subcronic 4-month oral toxicity study of dried Smallathus sonchifolius (yacon) roots as a diet supplementation in rats]]></article-title>
<source><![CDATA[Food and Chem Toxicol]]></source>
<year>2005</year>
<volume>43</volume>
<page-range>1657-1665</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Genta]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Habib]]></surname>
<given-names><![CDATA[NP]]></given-names>
</name>
<name>
<surname><![CDATA[Pons]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Manrique]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
<name>
<surname><![CDATA[Grau]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Yacon syrup: beneficial effects on obesity and insulin resistance in human]]></article-title>
<source><![CDATA[Clinical Nutr]]></source>
<year>2009</year>
<volume>28</volume>
<page-range>182-187</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Corcionivoschi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Drinceanu]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pop]]></surname>
<given-names><![CDATA[IM]]></given-names>
</name>
<name>
<surname><![CDATA[Stack]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Stef]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bourke]]></surname>
<given-names><![CDATA[CJB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The effect of probiotics on animal health]]></article-title>
<source><![CDATA[Animal Sc and Tecnol]]></source>
<year>2010</year>
<volume>43</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>35-41</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Konstantinov]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Awati]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Smidt]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Akkermans]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[de Vos]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Specific response of a novel and abundant Lactobacillus amylovorus-like phylotype to dietary prebiotics in the guts of weaning piglets]]></article-title>
<source><![CDATA[Appl Environ Microbiol]]></source>
<year>2004</year>
<volume>70</volume>
<page-range>3821-3830</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<collab>EFSA. European Food Safety Authority</collab>
<article-title xml:lang="en"><![CDATA[Opinion pf the scientific committee on a request from EFSA related to a generic approach to the safety assessment by EFSA o microorganisms used in food/feed additives]]></article-title>
<source><![CDATA[EFSA journal]]></source>
<year>2007</year>
<volume>22</volume>
<page-range>6 1-12</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baum]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Lieber-Tenorio]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Enss]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Pohlenz]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Breves]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Saccharomyces boulardii and Bacillus cereus var Toyoi influence the morphology and mucins of the intestine of pigs]]></article-title>
<source><![CDATA[Z Gastroenterol]]></source>
<year>2002</year>
<volume>40</volume>
<page-range>277-284</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinsachov]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Noy]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Comparison of post-hatch holding time and subsequent early performance of broiler hicks and turkey pouts]]></article-title>
<source><![CDATA[Br Poultry Sci]]></source>
<year>1993</year>
<volume>34</volume>
<page-range>111-120</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stern]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Svetoch]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Eruslanov]]></surname>
<given-names><![CDATA[BV]]></given-names>
</name>
<name>
<surname><![CDATA[Perelygin]]></surname>
<given-names><![CDATA[VV]]></given-names>
</name>
<name>
<surname><![CDATA[Mitsevich]]></surname>
<given-names><![CDATA[EV]]></given-names>
</name>
<name>
<surname><![CDATA[Mitsevich]]></surname>
<given-names><![CDATA[IP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Isolation o a Lactobacillus salivarius strain and purification of its bacteriocin, which is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system]]></article-title>
<source><![CDATA[Antimicrob Agents Chemother]]></source>
<year>2006</year>
<volume>50</volume>
<page-range>3111-3116</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nurmi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rantala]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[New aspects of Salmonella infection in broiler production]]></article-title>
<source><![CDATA[Nature]]></source>
<year>1973</year>
<volume>241</volume>
<page-range>210-211</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huggins]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Higgins]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Wollfenden]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Henderson]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
<name>
<surname><![CDATA[Torres-Rodriguez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tellez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Evaluation of a Lactobacillus based probiotic culture for the reduction of Salmonella enteriditis in neonatal broiler chicks]]></article-title>
<source><![CDATA[Poult Sci]]></source>
<year>2008</year>
<volume>87</volume>
<page-range>27-31</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haghighi]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Gong]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gyles]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Hayes]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Saneri]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Probiotics stimulates production of natural antibodies in chicken]]></article-title>
<source><![CDATA[Clin Vaccine Immunol]]></source>
<year>2006</year>
<volume>13</volume>
<page-range>975-980</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[lji]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Choc]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Dietary modulation of gut microflora in broiler chickens: a review of the role of six kinds of alternatives to in-feed antibiotics]]></article-title>
<source><![CDATA[World's Poultry Science Journal]]></source>
<year>2009</year>
<volume>65</volume>
<page-range>97-101</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mussato]]></surname>
<given-names><![CDATA[SI]]></given-names>
</name>
<name>
<surname><![CDATA[Mancilla]]></surname>
<given-names><![CDATA[IM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Non-digestible oligosaccharides: A review]]></article-title>
<source><![CDATA[Carbohydrate Polimers]]></source>
<year>2007</year>
<volume>68</volume>
<page-range>587-597</page-range></nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reid]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sanders]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Gaskins]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Gibson]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mercenier]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rastall]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[New Scientific Paradigms for probiotics and prebiotics]]></article-title>
<source><![CDATA[J Clin Gatroenterol]]></source>
<year>2003</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>105-118</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
